Back to BROWN BROTHERS HARRIMAN & CO BROWN BROTHERS HARRIMAN & CO

TCRXTCRX
9 quarters

Position history for BROWN BROTHERS HARRIMAN & COBROWN BROTHERS HARRIMAN & CO's holdings in TSCAN THERAPEUTICS INC

BROWN BROTHERS HARRIMAN & CO holds 143,051 shares of TCRX (TSCAN THERAPEUTICS INC), worth $140,204 as of 2026-Q2. TCRX represents 0.0% of BROWN BROTHERS HARRIMAN & CO's portfolio.

Current Value

$140,204

Current Shares

143,051

Total Value Change

-$304,536

Total Shares Change

+67,027

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
143,051
0.0%
$140,2040.0%$0.98
0
2026-Q1
Unchanged
143,051
0.0%
$144,4820.0%$1.03
0
2025-Q4
Unchanged
143,051
0.0%
$143,0510.0%$1.03
0
2025-Q3
Unchanged
143,051
0.0%
$260,3530.0%$1.74
0
2025-Q2
Unchanged
143,051
0.0%
$207,4240.0%$1.40
0
2025-Q1
Unchanged
143,051
0.0%
$197,4100.0%$1.35
0
2024-Q4
Unchanged
143,051
0.0%
$434,8750.0%$3.00
0
2024-Q3
Increased
143,051
+88.2%
$712,3940.0%$5.04
39
2024-Q2
New
76,024
-
$444,7400.0%$5.85
33

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used